Skip to search formSkip to main contentSkip to account menu

stage d2

Prostate cancer that has spread to distant lymph nodes or other organs.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Continuous androgen deprivation in stage C and D prostate cancer: Could the treatment be suspended?
4745 Purpose To evaluate whether patients (pts) with advanced prostate cancer (APC), programmed for continuous androgen… 
2004
2004
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
Although multiple studies have addressed the prognostic importance of tumor differentiation in patients with clinically localized… 
2003
2003
Induction of potent antitumour natural‐killer cells from peripheral blood of patients with advanced prostate cancer
In this section there are four papers on a variety of topics. The subject of antitumour natural killer cells is addressed in… 
Review
2002
Review
2002
Clinical significance of pulmonary metastases in stage D2 prostate cancer patients
Several prognostic factors such as the extent of bone metastases (EOD) in advanced prostate cancer (PCa) have been reported… 
Highly Cited
2001
Highly Cited
2001
Pretreatment serum level of testosterone as a prognostic factor in Japanese men with hormonally treated stage D2 prostate cancer.
Pretreatment serum level of testosterone (T) is a potential prognostic factor for prostate cancer. However, T levels in Japanese… 
1992
1992
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: Hormone regulatory effects in vivo
Natural killer (NK) cell activity was studied together with tumor marker serotests (PSA, PAP) and blood testosterone, estradiol… 
1992
1992
Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis
Background. A characteristic feature of prostatic adenocarcinoma is its great variation in biologic behavior. This variation and… 
1991
1991
Flow cytometric DNA analysis of stage D2 prostatic carcinoma.
Flow cytometric DNA analysis was performed on 34 samples of prostatic carcinoma patients with stage D2 disease to study the… 
Highly Cited
1991
Highly Cited
1991
Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?
Highly Cited
1980
Highly Cited
1980
I. Carcinoma of the rectum and rectosigmoid: Cancer specific long‐term survival. A series of 1061 cases treated by one surgeon
The long‐term cancer specific survival based on individual follow‐up and analysis of prospectively collected data from 1061… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)